4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sumitomo Chemical Company, Limited (4005) operates in the Chemicals industry and is headquartered in Tokyo, Japan with about 27,491 employees. Its market capitalization is roughly JPY 858 billion. In the fiscal year ended 2026-03-31, 4005 reported JPY 2.33T in revenue and JPY 60.9B in net income.
Sumitomo Chemical Company, Limited engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | JPY 2.33T | JPY 2.61T | JPY 2.45T | JPY 2.90T |
| Gross Profit | JPY 668.3B | JPY 725.5B | JPY 499.7B | JPY 820.9B |
| Operating Income (EBIT) | JPY 195.0B | JPY 172.4B | (JPY 431.4B) | (JPY 24.2B) |
| Net Income | JPY 60.9B | JPY 38.6B | (JPY 311.8B) | JPY 7.0B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Dividends Paid | (JPY 19.7B) | (JPY 9.9B) | (JPY 19.6B) | (JPY 42.5B) |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Assets | JPY 3.41T | JPY 3.44T | JPY 3.93T | JPY 4.17T |
| Total Liabilities | JPY 2.17T | JPY 2.37T | JPY 2.77T | JPY 2.68T |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4005 viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms